Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
342
NMPA:342
Drug Approvals
Cefazolin Sodium for Injection and Sodium Chloride Injection
- Product Name
- 注射用头孢唑林钠/氯化钠注射液
- Approval Number
- 国药准字H20254505
- Approval Date
- Jun 10, 2025
NMPA
Potassium Chloride Oral Solution
- Product Name
- 氯化钾口服溶液
- Approval Number
- 国药准字H20254422
- Approval Date
- Jun 3, 2025
NMPA
Ceftazidime for Injection and Sodium Chloride Injection
- Product Name
- 注射用头孢他啶/氯化钠注射液
- Approval Number
- 国药准字H20254122
- Approval Date
- May 13, 2025
NMPA
Biapenem for Injection and Sodium Chloride Injection
- Product Name
- 注射用比阿培南/氯化钠注射液
- Approval Number
- 国药准字H20254124
- Approval Date
- May 13, 2025
NMPA
Formoterol Fumarate Inhalation Solution
- Product Name
- 富马酸福莫特罗吸入溶液
- Approval Number
- 国药准字H20254001
- Approval Date
- Apr 22, 2025
NMPA
Vecuronium Bromide for Injection
- Product Name
- 注射用维库溴铵
- Approval Number
- 国药准字H20253997
- Approval Date
- Apr 22, 2025
NMPA
Imipenem and Cilastatin Sodium for Injection and Sodium Chloride Injection
- Product Name
- 注射用亚胺培南西司他丁钠/氯化钠注射液
- Approval Number
- 国药准字H20253281
- Approval Date
- Jan 24, 2025
NMPA
Tacrolimus Sustained-release Capsules
- Product Name
- 他克莫司缓释胶囊
- Approval Number
- 国药准字H20253165
- Approval Date
- Jan 14, 2025
NMPA
Tacrolimus Sustained-release Capsules
- Product Name
- 他克莫司缓释胶囊
- Approval Number
- 国药准字H20253166
- Approval Date
- Jan 14, 2025
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 35
- Next
Clinical Trials
No trials found
News
No news found